Integra LifeSciences | IART - Equity Capital And Reserves


Integra LifeSciences reported $1.04B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
CONMED USD 1.03B 24.83M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.34B 132.6M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
HeartBeam USD 2.6M 2.2M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Orthofix International USD 450.04M 7.55M Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025